TCT 2022: Edwards' Pascal Matches Abbott's MitraClip In CLASP IID
Executive Summary
Results of the CLASP IID trial showed Edwards’ Pascal mitral valve repair system was non-inferior for safety and effectiveness compared to Abbott’s MitraClip device.